Preparation, characterization and in vitro evaluation of cisplatin-bound triblock polymeric micelle solution for ovarian cancer treatment

References

• Reid BM, Permuth JB, Sellers TA, et al. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32.
   PubMed Web of Science ®Google Scholar
• Natarajan P, Taylor SE, Kirwan JM, et al. Ovarian cancer: current management and future directions. Obstet Gynaecol Reprod Med. 2018;28(6):171–176.
   Google Scholar
• Bast RC, Hennessy B, Mills GB Jr., et al. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9(6):415–428.
   PubMed Web of Science ®Google Scholar
• Chen VW, Ruiz B, Killeen JL, et al. Pathology and classification of ovarian tumors. Cancer. 2003;97(10 Suppl):2631–2642.
   PubMed Web of Science ®Google Scholar
• Javadi S, Ganeshan DM, Qayyum A, et al. Ovarian cancer, the revised FIGO staging system, and the role of imaging. AJR Am J Roentgenol. 2016;206(6):1351–1360.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869–1883.
   PubMed Web of Science ®Google Scholar
• Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019;88:102925.
   PubMed Web of Science ®Google Scholar
• Karbownik A, Szałek E, Urjasz H, et al. The physical and chemical stability of cisplatin (teva) in concentrate and diluted in sodium chloride 0.9%. WO. 2012;5(5):435–439.
   Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 2008;130(2):98–106.
   PubMed Web of Science ®Google Scholar
• Thanki K, Gangwal RP, Sangamwar AT, et al. Oral delivery of anticancer drugs: challenges and opportunities. J Control Release. 2013;170(1):15–40.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev. 2002;54(2):235–257.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73(2–3):137–172.
   PubMed Web of Science ®Google Scholar
• Homayun B, Lin X, Choi H-J, et al. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11(3):129.
   PubMed Web of Science ®Google Scholar
• Nelemans LC, Gurevich L. Drug delivery with polymeric nanocarriers—cellular uptake mechanisms. Materials. 2020;13(2):366.
   PubMed Web of Science ®Google Scholar
• Yang F, Xu J, Fu M, et al. Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin. J Drug Target. 2020;28(10):993–1011.
   Google Scholar
• Abd Karim KJ, Binauld S, Scarano W, et al. Macromolecular platinum-drugs based on statistical and block copolymer structures and their DNA binding ability. Polym Chem. 2013;4(22):5542–5554.
   Web of Science ®Google Scholar
• Binauld S, Scarano W, Stenzel MH, et al. pH-triggered release of platinum drugs conjugated to micelles via an acid-cleavable linker. Macromolecules. 2012;45(17):6989–6999.
   Web of Science ®Google Scholar
• Rezaei SJT, et al. Folate-decorated polymeric Pt(II) prodrug micelles for targeted intracellular delivery and cytosolic glutathione-triggered release of platinum anticancer drugs. Polym Chem. 2015;6:2844–2853.
   Google Scholar
• Chen Y, Zhang L, Liu Y, et al. Preparation of PGA–PAE-Micelles for Enhanced Antitumor Efficacy of Cisplatin. ACS Appl Mater Interfaces. 2018;10(30):25006–25016.
   Google Scholar
• Hassanen EI, Korany RMS, Bakeer AM, et al. Cisplatin‐conjugated gold nanoparticles‐based drug delivery system for targeting hepatic tumors. J Biochem Mol Toxicol. 2021;35(5):e22722.
   PubMed Web of Science ®Google Scholar
• Yang F, Xu J, Fu M, et al. Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin. J Drug Target. 2020;28(10):993–1011.
   PubMed Web of Science ®Google Scholar
• Ye H, Jin L, Hu R, et al. Poly(Ɣ, l-glutamic acid)–cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials. 2006;27(35):5958–5965.
   PubMed Web of Science ®Google Scholar
• Ouahab A, Cheraga N, Onoja V, et al. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG–PLA micelles for docetaxel delivery: in vitro study. Int J Pharm. 2014;466(1–2):233–245.
   PubMedGoogle Scholar
• Ak G, Sanlier SH. Synthesis of folate receptor-targeted and doxorubicin-coupled chemotherapeutic nanoconjugate and research into its medical applications. Prep Biochem Biotechnol. 2012;42(6):551–563.
   PubMed Web of Science ®Google Scholar
• Lopez-Flores A, Jurado R, Garcia-Lopez P, et al. High-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples. J Pharmacol Toxicol Methods. 2005;52(3):366–372.
   PubMedGoogle Scholar
• Toro-Córdova A, Ledezma-Gallegos F, Mondragon-Fuentes L, et al. Determination of liposomal cisplatin by high-performance liquid chromatography and its application in pharmacokinetic studies. J Chromatogr Sci. 2016;54(6):1016–1021.
   PubMed Web of Science ®Google Scholar
• Riisom M, Gammelgaard B, Lambert IH, et al. Development and validation of an ICP-MS method for quantification of total carbon and platinum in cell samples and comparison of open-vessel and microwave-assisted acid digestion methods. J Pharm Biomed Anal. 2018;158:144–150.
   PubMed Web of Science ®Google Scholar
• Stability Testing of new Drug Substances and Products. ICH Topic Q 1 A (R2), [London], 2003.
   Google Scholar
• Siepmann J, Siepmann F. Mathematical modeling of drug dissolution. Int J Pharm. 2013;453(1):12–24.
   PubMed Web of Science ®Google Scholar
• Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991;175(3):880–885.
   PubMed Web of Science ®Google Scholar
• Gundogdu E, Karasulu HY, Koksal C, et al. The novel oral imatinib microemulsions: physical properties, cytotoxicity activities and improved Caco-2 cell permeability. J Microencapsul. 2013;30(2):132–142.
   PubMed Web of Science ®Google Scholar
• Mayer A, Vadon M, Rinner B, et al. The role of nanoparticle size in hemocompatibility. Toxicology. 2009;258(2–3):139–147.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Chauhan N, Othman SF, et al. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomaterials. 2015;46:1–12.
   PubMed Web of Science ®Google Scholar
• Cole AJ, David AE, Wang J, et al. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32(8):2183–2193.
   PubMed Web of Science ®Google Scholar
• Semete B, Booysen L, Kalombo L, et al. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration. Int J Pharm. 2012;424(1–2):115–120.
   PubMedGoogle Scholar
• Kelland LR, Farrell N. Platinum-based drugs in cancer therapy. New Jersey (NJ): Springer; 2000.
   Google Scholar
• Wang Y, Liu Q, Qiu L, et al. Molecular structure, IR spectra, and chemical reactivity of cisplatin and transplatin: DFT studies, basis set effect and solvent effect. Spectrochim Acta A Mol Biomol Spectrosc. 2015;150:902–908.
   PubMed Web of Science ®Google Scholar
• Lin B, Li Z, Zhang H, et al. Cloning and expression of the γ-polyglutamic acid synthetase gene pgsBCA in Bacillus subtilis WB600 .Biomed Res Int. 2016;2016:3073949
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhao Y, Miao L, et al. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer. J Control Release. 2016;244(Pt A):63–73.
   PubMedGoogle Scholar
• Ramadan AM, Elsamra RMI, Bondock S, et al. New pyrazole-4-carbothioamide-based metal complexes: synthesis, spectral characterization, computational, antimicrobial, andantitumor investigations. Appl Organomet Chem. 2021;35(2):e6102.
   Web of Science ®Google Scholar
• Heitland P, Blohm M, Breuer C, et al. Application of ICP-MS and HPLC-ICP-MS for diagnosis and therapy of a severe intoxication with hexavalent chromium and inorganic arsenic. J Trace Elem Med Biol. 2017;41:36–40.
   PubMed Web of Science ®Google Scholar
• Hanafy N, El-Kemary M, Leporatti S, et al. Micelles structure development as a strategy to improve smart cancer therapy. Cancers (Basel). 2018;10(7):238.
   Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1–16.
   PubMed Web of Science ®Google Scholar
• Dash S, et al. Kinetic modelling on drug release from controlled drug delivery systems. Acta Pol Pharma. 2010;67(3):217–223.
   PubMed Web of Science ®Google Scholar
• Rastogi H, Jana S. Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells. Eur J Drug Metab Pharmacokinet. 2016;41(1):33–43.
   PubMed Web of Science ®Google Scholar
• Wang N, et al. The bioavailability of hepatoprotective flavonoids in hypericum japonicum extract. J Bioanal Biomed. 2009;1:33–38.
   Google Scholar
• Wang J, Wang L, Li Y, et al. Apically targeted oral micelles exhibit highly efficient intestinal uptake and oral absorption. Int J Nanomed. 2018;13:7997–8012.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Aggarwal P, Hall JB, et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5(4):487–495.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–3666.
   PubMed Web of Science ®Google Scholar
• Stojic L, Brun R, Jiricny J, et al. Mismatch repair and DNA damage signalling. DNA Repair (Amst)). 2004;3(8–9):1091–1101.
   PubMed Web of Science ®Google Scholar
• Staffhorst RWHM, van der Born K, Erkelens CAM, et al. Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts. Anticancer Drugs. 2008;19(7):721–727.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick GJ, Plumb JA, Sutcliffe OB, et al. Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin. J Inorg Biochem. 2011;105(9):1115–1122.
   PubMed Web of Science ®Google Scholar